切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (03) : 400 -403. doi: 10.3877/cma.j.issn.1673-5250.2013.03.032

所属专题: 文献

综述

产后避孕的研究进展
罗静雯1   
  1. 1. 400038 重庆,第三军医大学第一附属医院(西南医院)妇产科
  • 收稿日期:2013-01-05 修回日期:2013-04-25 出版日期:2013-06-01

Research Progress of Postpartum Contraception

Jing-wen LUO1   

  1. 1. Southwest Hospital, The Third Military University, Chongqing 400038, China
  • Received:2013-01-05 Revised:2013-04-25 Published:2013-06-01
  • About author:
    (Corresponding author: CHANG Qing, Email: )
引用本文:

罗静雯. 产后避孕的研究进展[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(03): 400-403.

Jing-wen LUO. Research Progress of Postpartum Contraception[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(03): 400-403.

产后1年内,由于子宫复旧和哺乳因素,女性生殖内分泌功能发生较大变化。产后1年内意外妊娠可严重影响妇女健康。目前国内外主要产后避孕方法包括哺乳期闭经避孕法(LAM)、屏障避孕法、宫内节育器(IUD)、激素避孕法及结扎避孕等。由于国内产后避孕尚未规范、系统化,因此,有效避免产后意外妊娠、降低高危人工终止妊娠术发生率及提高产后女性生殖健康是计划生育工作的重点。

Postpartum is a special period of the women's life when women have lots of changes in endocrine system, and therefore the undesired pregnancy during postpartum has serious influence on women's health.For now, the main methods of postpartum contraception at home and abroad including the lactational amenorrhea contraception(LAM), barrier contraception, intrauterine devices(IUD), hormonal contraception, ligation contraception and so on.However, there is no standard postpartum contraceptive system in China, How to reduce the undesired pregnancy during one year after postpartum, decrease the high risk abortions and promote the maternal and child health are the focus of family planning work.

[1]
Huang YM.Postpartum contraception[J].Chin J Pract Gynecol Obstertr, 2009, 25(10):731-733.
[2]
Tsui AO, Wasserheit JN, Haaga J.Reproductive health in developing countries: Expanding dimens[M].Washington DC:National Academy Press, 1997, 40-84.
[3]
Grisaru-Granovsky S, Gordon E, Haklai Z, et al.Effect of interpregnancy interval on adverse perinatal outcomes:A national study[J].Contraception, 2009, 80:512-518.
[4]
Conde-Agudelo A, Belizan JM.Maternal morbidity and mortality associated with interpregnancy interval:A cross-sectional study[J].BMJ, 2000, 321:1255-1259.
[5]
World Health Organization.Report of a WHO technical consultation on birth spacing[R].Geneva:WHO Press, 2005:1-48.
[6]
Huang YM, Kang JZ, Chen RZ, et al. Status of contraceptive adoption and service demand among postpartum women: A survey in Shanghai centre communities[J].Chin J Fam Plann, 2007, 141(7):501.
[7]
Chen CP.The Zhejiang countryside post-natal contraception condition and the birth control service investigates[J].Chin Man Rehabil Med, 2010, 1(5):120-121.
[8]
Centers for Disease Control and Prevention(CDC). Contraceptive use among postpartum women-12 states and New York City, 2004-2006[J].MMWR Morb Mortal Wkly Rep, 2009, 58(30):821-826.
[9]
DaVanzo J, Hale L, Razzaque A, et al.Effects of interp regnancyinterval and outcome of the preceding pregnancy on pregnancy outcomes in Matlab, Bangladesh[J].BJOG, 2007, 114(9):1079-1087.
[10]
Diaz S, Croxatto HB. Contraception in lactating women[J].Curr Opin Obstet Gynecol, 1993, 5:818-22.
[11]
Kennedy KI, Trussell J.Postpartum contraception and lactation//Hatcher RA, Trussell J, Nelson AL, et al.Contraceptive technology.19th ed[M].New York: Ardent Media, 2007:403-431.
[12]
Vekemans M.Postpartum contraception:The lactational amenorrhoea method[J].Eur J Contracep Reprod Health Care, 1997, 2(2):105-111.
[13]
World Health Organization.Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs(CCP), INFO project.Family planning:A global handbook for providers[M].Baltimore and Geneva:CCP and WHO, 2007, 1-372.
[14]
Xu JX, Shi TL, Zhou XB, et al.Contraceptive efficacy of bioadhesive nonoxynol-9 gel:Comparison with nonoxynol-9 suppository[J].Chin J Obstet Gynecol, 2003, 38(10):629-631.
[15]
Zhao HX, Wu JQ, Li YY, et al.Selection and use of contraceptive methods among internal migrant workers in three large Chinese cities: A workplace-based survey[J]. Eur J Contracept Reprod Health Care, 2011, 16(4):277-88.
[16]
Chi IC, Farr G.Postpartum IUD contraception:A review of an international experience[J].Adv Contracept, 1989, 5(3):127-146.
[17]
FFPRHC Guidance.Contraceptive choices for breastfeeding women[J].J Fam Plann Reprod Health Care, 2004, 30(3):181-189.
[18]
Farley TM, Rosenburg MJ, Rowe PJ, et al.Intrauterine devices and pelvic inflammatory disease: An international perspective[J].Lancet, 1992, 339:785-788.
[19]
Xu JX, Reusche C, Burdan A.Immediate postplacental insertion of the intrauterine device:A review of Chinese and the world's experiences[J].Adv Contracept, 1994, 10(1):71-82.
[20]
Min L, Xu KH.Clinical investigation of levonorgestrel-releasing intrauterine system[J/CD].Chin J Obstet Gynecol Pediatr:Electron Ed, 2012, 8(3):335-336.
[21]
World Health Organization.Statement:Progestogen-only contraceptive use during lactation and its effects on the neonate[R].Geneva:WHO Press, 2008.
[22]
Kapp N, Curtis K, Nanda K.Progestogen-only contraceptive use among breastfeeding women:A systematic review[J].Contraception, 2010, 82(1):17-37.
[23]
World Health Organization.Technical consultation on hormonal contraceptiveuse during lactation and effects on the newborn:Summary report[R].Geneva:WHO Press, 2010.
[24]
Costa ML, Cecatti JG, Krupa FG, et al.Progestin-only contraception prevents bone loss in postpartum breastfeeding women[J].Contraception, 2012, 85(4):374-80.
[25]
Liu CD, Weng LJ.Pure progestin contraceptive the safety and efficacy:The epidemiological view[J].Foreign Med Fam Plan, 1994, 13(1):28-30.
[26]
WHO Task Force on Oral Contracep tives.Effects of hormonal conracep tives on breastmilk composition and infant growth[J].Stud Fam Plann, 1988, 19(6):361-369.
[27]
Hannon PR, Duggan AK, Serwint JR, et al.The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community[J].Arch Pediatr Adolesc Med, 1997, 151(5):490-496.
[28]
Kaunitz AM.Injectable depot medroxyprogesterone acetate contraception-an update for U.S. clinicians[J].Int J Fertil Women's Med, 1998, 43:73-83.
[29]
Templeman CL, Cook V, Goldsmith LJ, et al.Postpartum contraceptive use among adolescent mothers[J].Obstet Gynecol, 2000, 95(5):770-776.
[30]
Qiao YH, Fang HL, Jiang LF.150 cases of lactation women with acetic acid medroxyprogesterone acetate of acceptability and evaluation[J].Clin Med, 2005, 08:39-40.
[31]
Isley MM, Edelman A.Contraceptive implants:An overview and update[J].Obstet Gynecol Clin North Am, 2007, 34(1):73-90.
[32]
Tu P, Qiu S, Fang H, et al.Acceptance, efficacy, and side effects of Norplant implants in four counties in north China[J].Stud Fam Plann, 1997, 28(2):122-131.
[33]
World Health Organization.Medical eligibility criteria for contraceptive Use[R].Geneva:WHO press, 2000.
[34]
Truitt ST, Fraser AB, Grimes DA, et al.Hormonal contraception during lactation:Systematic Review of randomized controlled trials[J].Contraception, 2003, 68:233-238.
[35]
Jackson E.Controversies in postpartum contraception:When is it safe to start oral contraceptives after childbirth[J]? Thromb Res, 2011, 127 (3):35-39.
[36]
Huang ZR, Wu SC.Oral contraceptive development and the present condition of the usage[J].J Int Reprod Health/Fam plan, 2009, 28(3):139-141.
[37]
Gainer E, Massai R, Lillo S, et al. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception[J].Hum Reprod, 2007, 22(6):1578-1584.
[38]
Cheng LN.Postpartum contraceptive technology progress[J].Chin J Pract Gynecol Obstertr, 2001, 17(9):516-518.
[1] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[2] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[3] 陈莉, 雷雪芹, 段炼, 曾悦, 何国琳. 影响2次剖宫产术后阴道试产产妇试产成功因素及妊娠结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 287-294.
[4] 吴晶晶, 胡倩, 李华凤. 围产期焦虑/抑郁与分娩疼痛相关性的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 156-161.
[5] 沈立平, 龙驭云, 杨月华, 张敏, 许阳, 赵亚丽, 李静, 张昀, 江世文, 孙志明. 不同避孕方式对女性再次受孕的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 107-112.
[6] 赵春桃, 梁峰雪, 杨瑞敏, 陈云璇, 陈曦, 焦桂清. 三维盆底超声预测产妇发生盆腔脏器脱垂的价值及影响因素[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 606-614.
[7] 朱丽丽, 李冰, 薛静, 于慧, 李淑红. 椎管内分娩镇痛对经阴道分娩初产妇产后早期盆底功能的影响[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 484-491.
[8] 李炳根, 龚独辉, 赖泽如, 聂向阳. 产后腹直肌分离全腔镜下肌后/腹膜外补片修补术的临床研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 724-727.
[9] 朱琳, 刘宁. 地诺孕素治疗复发性卵巢子宫内膜异位囊肿的临床研究[J]. 中华临床医师杂志(电子版), 2022, 16(06): 519-523.
[10] 唐䶮, 唐卉, 陈悦, 李慕军. 前置胎盘剖宫产改良术式预防产后出血的探讨[J]. 中华临床医师杂志(电子版), 2022, 16(05): 436-441.
[11] 王永, 李霞林, 杨蓉, 潘康妮, 余琳, 王伟伟, 孙雯, 陈敦金. 胎盘植入合并严重产后出血输血方案的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 173-179.
[12] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
[13] 肖美群, 朱薇, 符华影. 产后急性子宫内翻四例临床分析[J]. 中华产科急救电子杂志, 2023, 12(02): 113-117.
[14] 黄畅晓, 李力. 预防产后出血关口前移的策略[J]. 中华产科急救电子杂志, 2022, 11(04): 198-201.
[15] 温洁, 陈丹青. 妊娠合并缺铁性贫血与产后出血的管理[J]. 中华产科急救电子杂志, 2022, 11(04): 217-221.
阅读次数
全文


摘要